DISCOUNT ZERTIFIKAT - NOVARTIS N Share Price

Certificat

DE000ME1RE22

Market Closed - Börse Stuttgart 09:30:58 21/06/2024 pm IST
72.69 EUR -0.23% Intraday chart for DISCOUNT ZERTIFIKAT - NOVARTIS N
Current month+2.65%
1 month+3.62%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
21/24/21 72.69 -0.23%
20/24/20 72.86 -0.30%
19/24/19 73.08 -0.05%
18/24/18 73.12 +0.67%
17/24/17 72.63 -0.34%

Delayed Quote Börse Stuttgart

Last update June 21, 2024 at 09:30 pm IST

More quotes

Static data

Product typeDiscount Certificates
Buy / SellCALL
Underlying NOVARTIS AG
Issuer Morgan Stanley
WKN ME1RE2
ISINDE000ME1RE22
Date issued 09/10/2023
Maturity 20/12/2024 (181 Days)
Parity 1 : 1
Emission price 71
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 73.63
Lowest since issue 69.74
Spread 0.02
Spread %0.03%

Company Profile

Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales (excluding discontinued operations) break down by therapeutic area as follows: - oncology (29.9%); - immunology (17.2%); - cardiovascular, renal and metabolic diseases (14.1%); - neuroscience (8.9%). The remaining net sales (29.9%) are from contract manufacturing of pharmaceutical products. At the end of 2023, Novartis AG had 33 production sites worldwide. Net sales are distributed geographically as follows: Europe (33%), the United States (39.5%), Asia/Africa/Australasia (20.5%), Canada and Latin America (7%).
Sector
-
More about the company

Ratings for Novartis AG

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Novartis AG

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
105.1 USD
Average target price
110.3 USD
Spread / Average Target
+4.97%
Consensus